Powered by the NovaSeq X Plus 10B flowcell, we can sequence up to 64 human genomes at 90 Gb coverage in as little as 24 hours.
With up to 3 Tb of raw data output per flow cell, 375 Gb per lane, and 2 × 150 bp read lengths, the platform enables rapid, high-throughput sequencing for population-scale and large cohort studies.
The PacBio Revio® platform combines highly accurate long reads with direct methylation detection, delivering up to 360 Gb of HiFi data per day. With high throughput, exceptional accuracy, and scalable performance, it supports applications including whole-genome sequencing, structural variant analysis, and de novo genome assembly.
The Oxford Nanopore PromethION™ platform delivers scalable, real-time long-read sequencing for DNA and RNA. Ultra-long reads span complex genomic regions, enabling high-quality genome assembly, structural variant detection, epigenetic analysis, and transcriptome characterization for a wide range of research applications.
The DNBSEQ-T7™ platform can generate up to 7 Tb of data per run (PE150), making it ideal for data-intensive applications such as whole genome sequencing and other large-scale sequencing projects.
We offer both PE150 and PE100 sequencing options, providing the flexibility and scalability to support a wide range of research requirements.
The Chromium X Series enables high-throughput single-cell analysis at scale, making it ideal for applications such as single-cell gene expression, immune profiling, multiome, and spatial biology studies.
Its scalable workflows and robust performance provide the flexibility and reproducibility required for a wide range of research projects.
The Visium CytAssist platform enables spatial gene expression profiling while preserving tissue context, making it ideal for applications in oncology, neuroscience, immunology, and developmental biology.
Its robust workflow provides researchers with deeper insights into tissue architecture, cellular interactions, and disease mechanisms.
The Xenium platform enables high-resolution spatial analysis with single-cell and subcellular precision, allowing researchers to visualize and quantify gene expression directly within intact tissues.
It is ideal for applications in oncology, immunology, neuroscience, and translational research. By combining spatial context with targeted gene expression profiling, Xenium helps researchers gain deeper insights into cellular interactions, tissue architecture, and disease mechanisms.
The Orbitrap™ Exploris™ 120 platform enables comprehensive proteomics and metabolomics analysis with high-resolution and accurate-mass detection.
It supports applications ranging from biomarker discovery and pathway analysis to translational and clinical research. Its robust performance and high sensitivity provide researchers with reliable, high-quality data for deeper biological understanding.
The Olink® Proteomics platform enables high-throughput protein biomarker discovery with exceptional specificity and sensitivity.
Supporting both Olink® Explore HT and Olink® Reveal workflows, the platform provides comprehensive protein profiling for applications including biomarker discovery, disease research, population studies, and translational research. Its scalable and highly reproducible workflows help researchers generate reliable proteomic data and gain deeper insights into biological pathways and disease mechanisms.
Powered by the NovaSeq X Plus 10B flowcell, we can sequence up to 64 human genomes at 90 Gb coverage in as little as 24 hours.
With up to 3 Tb of raw data output per flow cell, 375 Gb per lane, and 2 × 150 bp read lengths, the platform enables rapid, high-throughput sequencing for population-scale and large cohort studies.
The PacBio Revio® platform combines highly accurate long reads with direct methylation detection, delivering up to 360 Gb of HiFi data per day. With high throughput, exceptional accuracy, and scalable performance, it supports applications including whole-genome sequencing, structural variant analysis, and de novo genome assembly.
The Oxford Nanopore PromethION™ platform delivers scalable, real-time long-read sequencing for DNA and RNA. Ultra-long reads span complex genomic regions, enabling high-quality genome assembly, structural variant detection, epigenetic analysis, and transcriptome characterization for a wide range of research applications.
The DNBSEQ-T7™ platform can generate up to 7 Tb of data per run (PE150), making it ideal for data-intensive applications such as whole genome sequencing and other large-scale sequencing projects.
We offer both PE150 and PE100 sequencing options, providing the flexibility and scalability to support a wide range of research requirements.
The Chromium X Series enables high-throughput single-cell analysis at scale, making it ideal for applications such as single-cell gene expression, immune profiling, multiome, and spatial biology studies.
Its scalable workflows and robust performance provide the flexibility and reproducibility required for a wide range of research projects.
The Visium CytAssist platform enables spatial gene expression profiling while preserving tissue context, making it ideal for applications in oncology, neuroscience, immunology, and developmental biology.
Its robust workflow provides researchers with deeper insights into tissue architecture, cellular interactions, and disease mechanisms.
The Xenium platform enables high-resolution spatial analysis with single-cell and subcellular precision, allowing researchers to visualize and quantify gene expression directly within intact tissues.
It is ideal for applications in oncology, immunology, neuroscience, and translational research. By combining spatial context with targeted gene expression profiling, Xenium helps researchers gain deeper insights into cellular interactions, tissue architecture, and disease mechanisms.
The Orbitrap™ Exploris™ 120 platform enables comprehensive proteomics and metabolomics analysis with high-resolution and accurate-mass detection.
It supports applications ranging from biomarker discovery and pathway analysis to translational and clinical research. Its robust performance and high sensitivity provide researchers with reliable, high-quality data for deeper biological understanding.
The Olink® Proteomics platform enables high-throughput protein biomarker discovery with exceptional specificity and sensitivity.
Supporting both Olink® Explore HT and Olink® Reveal workflows, the platform provides comprehensive protein profiling for applications including biomarker discovery, disease research, population studies, and translational research. Its scalable and highly reproducible workflows help researchers generate reliable proteomic data and gain deeper insights into biological pathways and disease mechanisms.